Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01756833 · ClinicalTrials.gov registry record · Phase 2
Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial
A Phase 2 study of Aneurysm, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- Phase 2
- Development phase
- 261
- Enrollment target
- 20
- Study locations
NCT01756833 is a Phase 2 study of Aneurysm that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 261 participants, below the 17,053-participant average among 6 other Aneurysm trials with a reported enrollment target (98% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT01756833, a Phase 2 study of Aneurysm, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 261 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary aim of this study is to determine if doxycycline (100 mg bid) will inhibit (by at least 40%) the increase in greatest transverse diameter of small abdominal aortic aneurysms (3.5-5.0 cm in men, 3.5-4.5 cm in women) over a 24-month period of observation in comparison to a placebo-treated control group.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Doxycycline
Study Locations (20)
Arizona
- University of Arizona Medical Center - Tucson
- Carondelet Heart & Vascular Institute - Tucson
California
- University of Southern California - Los Angeles
- Stanford University - Stanford
Florida
- Miami Cardiac and Vascular Institute - Miami
- University of South Florida Health Center - Tampa
Michigan
- University of Michigan Medical Center - Ann Arbor
- McLaren Northern Michigan - Petoskey
Nebraska
- Omaha VAMC - Omaha
- University of Nebraska Medical Center - Omaha
Oregon
- Oregon Health Sciences University - Portland
- Portland VAMC - Portland
Illinois
- Northwestern University Memorial Hospital - Chicago
Maryland
- University of Maryland Medical Center - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 261 participants |
| Start Date | 2013-05 |
| Est. Completion | 2019-07-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01756833
The ClinicalTrials.gov registry entry for NCT01756833 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 261 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 17,053-participant average among 6 other Aneurysm trials with a reported enrollment target (98% lower). The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aneurysm appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01756833 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Arizona, California, Florida.
Frequently Asked Questions
What is clinical trial NCT01756833 about?
NCT01756833 is a clinical study titled "Non-Invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial". The primary aim of this study is to determine if doxycycline (100 mg bid) will inhibit (by at least 40%) the increase in greatest transverse diameter of small abdominal aortic aneurysms (3.5-5.0 cm in men, 3.5-4.5 cm in women) over a 24-month period of observation in comparison to a placebo-treated ...
What is the current status of trial NCT01756833?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 261 participants. The study started on 2013-05. Estimated completion is 2019-07-23.
What conditions does trial NCT01756833 study?
This clinical trial studies the following conditions: Aneurysm.
What interventions are being tested in trial NCT01756833?
The interventions under investigation include: Placebo (DRUG), Doxycycline (DRUG).
Who is sponsoring clinical trial NCT01756833?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01756833 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aneurysm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.
RECRUITING
-
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
RECRUITING · Phase 1
-
Evaluation of Flow Diverter Technology Device for Intracranial Aneurysm (SHIELD)
RECRUITING · NA
-
PANTHER Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches
RECRUITING
-
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
RECRUITING · NA
-
Doppler Flow Wires in Cerebral Angiography
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.